Limitations of structural allograft in revision total knee Arthroplasty

Ryan D. Bauman, David G. Lewallen, Arlen D. Hanssen

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Management of large bone defects in total knee arthroplasty (TKA) usually has involved modular prostheses with metal augments, structural allografts, and megaprostheses. We retrospectively reviewed the outcome of treatment of major bone defects for 74 patients (79 knees) who had revision TKAs with structural allografts; nine patients were lost to followup before 5 years, leaving 65 patients (70 knees, or 88%) followed for a minimum of 5 years or until revision or death. Medical records, radiographs, patient surveys, and correspondence were used for all data. Sixteen patients (22.8%) had failed reconstructions and underwent additional revision surgery; eight of the 16 were secondary to allograft failure, three were secondary to failure of a component not supported by allograft, and five were secondary to infection. In patients not requiring revision surgery, the Knee Society score improved from 49 preoperatively to 87 postoperatively. We observed revision-free survival of 80.7% (95% confidence interval, 71.7-90.8) at 5 years and 75.9% (95% confidence interval, 65.6-87.8) at 10 years. Our data support the selective use of structural allograft for large cavitary defects encountered during TKA. However, the rates of complications and reoperations suggest efforts to improve results or develop more durable alternative methods are warranted for these challenging reconstructions. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Original languageEnglish (US)
Pages (from-to)818-824
Number of pages7
JournalClinical Orthopaedics and Related Research
Volume467
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Knee Replacement Arthroplasties
Allografts
Reoperation
Knee
Confidence Intervals
Bone and Bones
Coinfection
Prostheses and Implants
Medical Records
Metals
Guidelines
Survival

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Limitations of structural allograft in revision total knee Arthroplasty. / Bauman, Ryan D.; Lewallen, David G.; Hanssen, Arlen D.

In: Clinical Orthopaedics and Related Research, Vol. 467, No. 3, 03.2009, p. 818-824.

Research output: Contribution to journalArticle

Bauman, Ryan D. ; Lewallen, David G. ; Hanssen, Arlen D. / Limitations of structural allograft in revision total knee Arthroplasty. In: Clinical Orthopaedics and Related Research. 2009 ; Vol. 467, No. 3. pp. 818-824.
@article{3b692229913748c88789f2b01bd0bc4a,
title = "Limitations of structural allograft in revision total knee Arthroplasty",
abstract = "Management of large bone defects in total knee arthroplasty (TKA) usually has involved modular prostheses with metal augments, structural allografts, and megaprostheses. We retrospectively reviewed the outcome of treatment of major bone defects for 74 patients (79 knees) who had revision TKAs with structural allografts; nine patients were lost to followup before 5 years, leaving 65 patients (70 knees, or 88{\%}) followed for a minimum of 5 years or until revision or death. Medical records, radiographs, patient surveys, and correspondence were used for all data. Sixteen patients (22.8{\%}) had failed reconstructions and underwent additional revision surgery; eight of the 16 were secondary to allograft failure, three were secondary to failure of a component not supported by allograft, and five were secondary to infection. In patients not requiring revision surgery, the Knee Society score improved from 49 preoperatively to 87 postoperatively. We observed revision-free survival of 80.7{\%} (95{\%} confidence interval, 71.7-90.8) at 5 years and 75.9{\%} (95{\%} confidence interval, 65.6-87.8) at 10 years. Our data support the selective use of structural allograft for large cavitary defects encountered during TKA. However, the rates of complications and reoperations suggest efforts to improve results or develop more durable alternative methods are warranted for these challenging reconstructions. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.",
author = "Bauman, {Ryan D.} and Lewallen, {David G.} and Hanssen, {Arlen D.}",
year = "2009",
month = "3",
doi = "10.1007/s11999-008-0679-4",
language = "English (US)",
volume = "467",
pages = "818--824",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Limitations of structural allograft in revision total knee Arthroplasty

AU - Bauman, Ryan D.

AU - Lewallen, David G.

AU - Hanssen, Arlen D.

PY - 2009/3

Y1 - 2009/3

N2 - Management of large bone defects in total knee arthroplasty (TKA) usually has involved modular prostheses with metal augments, structural allografts, and megaprostheses. We retrospectively reviewed the outcome of treatment of major bone defects for 74 patients (79 knees) who had revision TKAs with structural allografts; nine patients were lost to followup before 5 years, leaving 65 patients (70 knees, or 88%) followed for a minimum of 5 years or until revision or death. Medical records, radiographs, patient surveys, and correspondence were used for all data. Sixteen patients (22.8%) had failed reconstructions and underwent additional revision surgery; eight of the 16 were secondary to allograft failure, three were secondary to failure of a component not supported by allograft, and five were secondary to infection. In patients not requiring revision surgery, the Knee Society score improved from 49 preoperatively to 87 postoperatively. We observed revision-free survival of 80.7% (95% confidence interval, 71.7-90.8) at 5 years and 75.9% (95% confidence interval, 65.6-87.8) at 10 years. Our data support the selective use of structural allograft for large cavitary defects encountered during TKA. However, the rates of complications and reoperations suggest efforts to improve results or develop more durable alternative methods are warranted for these challenging reconstructions. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

AB - Management of large bone defects in total knee arthroplasty (TKA) usually has involved modular prostheses with metal augments, structural allografts, and megaprostheses. We retrospectively reviewed the outcome of treatment of major bone defects for 74 patients (79 knees) who had revision TKAs with structural allografts; nine patients were lost to followup before 5 years, leaving 65 patients (70 knees, or 88%) followed for a minimum of 5 years or until revision or death. Medical records, radiographs, patient surveys, and correspondence were used for all data. Sixteen patients (22.8%) had failed reconstructions and underwent additional revision surgery; eight of the 16 were secondary to allograft failure, three were secondary to failure of a component not supported by allograft, and five were secondary to infection. In patients not requiring revision surgery, the Knee Society score improved from 49 preoperatively to 87 postoperatively. We observed revision-free survival of 80.7% (95% confidence interval, 71.7-90.8) at 5 years and 75.9% (95% confidence interval, 65.6-87.8) at 10 years. Our data support the selective use of structural allograft for large cavitary defects encountered during TKA. However, the rates of complications and reoperations suggest efforts to improve results or develop more durable alternative methods are warranted for these challenging reconstructions. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

UR - http://www.scopus.com/inward/record.url?scp=60549109254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549109254&partnerID=8YFLogxK

U2 - 10.1007/s11999-008-0679-4

DO - 10.1007/s11999-008-0679-4

M3 - Article

C2 - 19130161

AN - SCOPUS:60549109254

VL - 467

SP - 818

EP - 824

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 3

ER -